The lives of close to 600 million people worldwide are deeply affected by mitral insufficiency and urinary incontinence. Those with mitral insufficiency must undergo major surgery to avoid all cardiac problems, or even simply to survive. As for urinary incontinence, sufferers change their social life due to leaking, and have to make do with solutions that are difficult to implant and use. All expect easier solutions from modern medicine.
Which is what Affluent offers, with three leading-edge solutions: minimally invasive, adjustable and modelled on the human anatomy. Kalios™ and Epygon treat mitral insufficiency, and Artus treats urinary incontinence.
At the clinical phase today, each of these innovations will be available starting in 2027.
Solutions at the Clinical Phase of Study, and Soon Accessible for Everyone
Mitral valve repair
Mitral valve replacement